NGF and Alzheimer disease: A transgenic mouse line expressing recombinant neutralizing anti-nerve growth factor (NGF) antibodies (AD11 mice) display similar pathological hallmarks to AD such as amyloid plaque and neurofibrillary tangle deposition, neurodegeneration, long-term potentiation (LTP) deficits, and behavioral abnormalities (72–75).